Back to today’s briefing

Story perspectives

PCI Pharma Surges to $10 Billion Valuation Amid Investment Boom

7/14/2025

43 9

Summary

Story summary

Private equity giants like Bain Capital and Kolberg have poured investments into PCI Pharma Services, propelling its valuation to an impressive $10 billion. This contract drug development powerhouse, boasting over 8,000 employees, is set to enhance its manufacturing capabilities and global presence. In just five years, PCI has successfully launched over 450 products, including the notable Wegovy from Novo Nordisk.

1 of 1

Story summary

Private equity giants like Bain Capital and Kolberg have poured investments into PCI Pharma Services, propelling its valuation to an impressive $10 billion. This contract drug development powerhouse, boasting over 8,000 employees, is set to enhance its manufacturing capabilities and global presence. In just five years, PCI has successfully launched over 450 products, including the notable Wegovy from Novo Nordisk.